FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer
Open Access
- 22 August 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 31 (14), 1845-1858
- https://doi.org/10.1038/onc.2011.368
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer modelBMC Cancer, 2010
- Sulforaphane inhibits angiogenesis through activation of FOXO transcription factorsOncology Reports, 2009
- A brief introduction to FOXOlogyOncogene, 2008
- FOXO animal models reveal a variety of diverse roles for FOXO transcription factorsOncogene, 2008
- The FoxO codeOncogene, 2008
- Induction of Mxi1-SRα by FOXO3a Contributes to Repression of Myc-Dependent Gene ExpressionMolecular and Cellular Biology, 2007
- Epidermal Growth Factor Receptor Inhibitors in Cancer TreatmentFuture Oncology, 2005
- Direct transcriptional regulation of Bim by FoxO3a mediates STI571-induced apoptosis in Bcr-Abl-expressing cellsOncogene, 2005
- Genomic Maps and Comparative Analysis of Histone Modifications in Human and MouseCell, 2005
- Acetylated histone H4 is preferentially associated with template-active chromatin.Proceedings of the National Academy of Sciences of the United States of America, 1978